Melazyme
PrivateLast Round
Seed
May 14, 2026
Total Funding Raised
$2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Melazyme is a biotechnology company that uses a precision fermentation platform to develop functional biomolecules.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Fashion & Beauty, Water Treatment, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Melazyme Comparables
Compare Melazyme with similar companies based on industry and business-model similarity.
Melazyme Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 14, 2026 |
Melazyme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Stellaris Venture Partners | Seed |
| Plug and Play Tech Center | Seed |
| SeaX Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
$2M round led by SeaX Ventures
Melazyme Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Melazyme's valuation, stock price, and market status.
Is Melazyme a public or private company?
Melazyme is a private company.
What is the current stock price of Melazyme?
Melazyme is a private company with no public stock price. No recent secondary market data is available.
How much is Melazyme worth (valuation)?
Valuation information for Melazyme is not publicly available.
Can I buy Melazyme stock?
Melazyme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Melazyme's last funding round?
Melazyme's most recent funding round was Seed on May 14, 2026.
Who are the main investors in Melazyme?
Key investors in Melazyme include SeaX Ventures.
Will Melazyme IPO soon?
No public IPO plans have been announced for Melazyme.
How can I track Melazyme secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Melazyme's secondary market activity and sign up for updates.